Chromogranin A: a useful biomarker in castration-resistant prostate cancer

PURPOSE: The natural history of prostate cancer (PC) almost always evolves to castration-resistant prostate cancer (CRPC) status, sometimes comprising pure or mixed neuroendocrine prostate cancers (NEPC) differentiation. In CRPC, monitoring using only prostate-specific antigen (PSA) is not optimal s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ploussard, Guillaume, Rozet, François, Roubaud, Guilhem, Stanbury, Trevor, Sargos, Paul, Roupret, Morgan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947027/
https://www.ncbi.nlm.nih.gov/pubmed/36527470
http://dx.doi.org/10.1007/s00345-022-04248-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947027/
https://www.ncbi.nlm.nih.gov/pubmed/36527470
http://dx.doi.org/10.1007/s00345-022-04248-0

Ejemplares similares